Could a common antioxidant save newborns from deadly sepsis?
NCT ID NCT07380347
First seen Feb 02, 2026 · Last updated Jun 15, 2026 · Updated 16 times
Summary
This study tests whether adding N-acetylcysteine (NAC) to standard care helps newborns with sepsis. Sepsis causes dangerous inflammation and cell damage. NAC may reduce this damage by boosting the body's defenses. The trial will enroll 50 near-term and term infants to see if NAC improves organ function, lowers hospital stay, and reduces death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.